remacemide has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asghar, AU; Hasan, SS; King, AE | 2 |
2 other study(ies) available for remacemide and Innate Inflammatory Response
| Article | Year |
|---|---|
The anticonvulsant remacemide and its metabolite AR-R12495AA attenuate spinal synaptic transmission and carrageenan-induced inflammation in the young rat.
Topics: Acetamides; Animals; Anterior Horn Cells; Anticonvulsants; Carrageenan; Electrophysiology; Excitatory Postsynaptic Potentials; In Vitro Techniques; Inflammation; Membrane Potentials; Neurons, Afferent; Phenethylamines; Rats; Rats, Wistar; Spinal Cord; Synaptic Transmission | 2000 |
Actions of the anticonvulsant remacemide metabolite AR-R12495AA on afferent-evoked spinal synaptic transmission in vitro and on models of acute and chronic inflammation in the rat.
Topics: Acetamides; Acute Disease; Afferent Pathways; Animals; Animals, Newborn; Anticonvulsants; Chronic Disease; Dizocilpine Maleate; Electric Stimulation; Electrophysiology; Excitatory Amino Acid Antagonists; Hyperalgesia; In Vitro Techniques; Inflammation; Phenethylamines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Spinal Nerve Roots; Synaptic Transmission | 2000 |